SCHEMBL10074033

SCHEMBL10074033

Cc1cc(Cc2cc(C)c(N3C(=O)C=CC3=O)c(C(C)C)c2)cc(C(C)C)c1N1C(=O)C=CC1=O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 9/20 0.40
FAAH O00519 2/20 0.40
HSP90AA1 P07900 3/20 0.34
CCR6 P51684 2/20 0.34
THRA P10827 3/20 0.32
THRB P10828 3/20 0.32
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
NLRP1 Q9C000 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
GSR P00390 1/20 0.31
HMGB1 P09429 1/20 0.30
CXCL12 P48061 1/20 0.30
CNR2 P34972 1/20 0.30
GPR55 Q9Y2T6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30389708 1.00 MGLL (0.40) MGLLFAAHHSP90AA1CCR6THRA
SCHEMBL22310888 0.92 MGLL (0.35) MGLLFAAHHPGD
SCHEMBL8854665 0.90 MGLL (0.44) MGLLFAAHHSP90AA1CCR6GSR
SCHEMBL184674 0.84 MGLL (0.45) MGLLFAAHHSP90AA1CCR6ALDH1A1
SCHEMBL10073999 0.83 MGLL (0.39) MGLLFAAHHSP90AA1CCR6
SCHEMBL22728182 0.79 MGLL (0.41) MGLLFAAHHSP90AA1CCR6THRA
SCHEMBL12586551 0.77 RAB9A (0.34) ALDH1A1PKMHPGDHTTNPSR1
SCHEMBL184912 0.77 MGLL (0.41) MGLLFAAHHSP90AA1CCR6ALDH1A1
SCHEMBL29386487 0.77 MGLL (0.41) MGLLFAAHHSP90AA1CCR6ALDH1A1
SCHEMBL29649706 0.77 MGLL (0.41) MGLLFAAHHSP90AA1CCR6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3551675-A1 RESIN COMPOSITIONS Novoset, LLC (US) 2019-10-16 EP claimed
US-10358418-B2 Resin compositions NOVOSET, LLC (US) 2019-07-23 US claimed
WO-2018111337-A1 RESIN COMPOSITIONS NOVOSET, LLC (US) 2018-06-21 WO claimed
US-11685808-B2 Oligomer resin compositions NOVOSET, LLC (US) 2023-06-27 US disclosed
EP-4165127-A1 OLIGOMER RESIN COMPOSITIONS Novoset, LLC (US) 2023-04-19 EP disclosed
US-20220411573-A1 OLIGOMER RESIN COMPOSITIONS NOVOSET, LLC (US) 2022-12-29 US disclosed
EP-3551675-B1 RESIN COMPOSITIONS NOVOSET LLC (US) 2022-11-09 EP disclosed
WO-2021252728-A1 OLIGOMER RESIN COMPOSITIONS NOVOSET, LLC (US) 2021-12-16 WO disclosed
EP-3919566-A1 THERMOSETTING RESIN COMPOSITION, PREPREG CONTAINING SAME, METAL FOIL-CLAD LAMINATE AND PRINTED CIRCUIT BOARD Shengyi Technology Co., Ltd. (CN) 2021-12-08 EP disclosed
US-11174385-B2 Resin composition and article made therefrom Elite Material Co., Ltd. (TW) 2021-11-16 US disclosed
US-20210032463-A1 RESIN COMPOSITION AND ARTICLE MADE THEREFROM Elite Material Co., Ltd. (TW) 2021-02-04 US disclosed
WO-2018111337-A1 RESIN COMPOSITIONS NOVOSET, LLC (US) 2018-06-21 WO disclosed
US-20180170873-A1 RESIN COMPOSITIONS NOVOSET LLC 2018-06-21 US disclosed
US-20180170873-A1 RESIN COMPOSITIONS NOVOSET LLC 2018-06-21 US disclosed
US-20180170873-A1 RESIN COMPOSITIONS NOVOSET LLC 2018-06-21 US disclosed
US-9902695-B1 Resin compositions NOVOSET LLC (US) 2018-02-27 US disclosed
US-9902695-B1 Resin compositions NOVOSET LLC (US) 2018-02-27 US disclosed
US-9902695-B1 Resin compositions NOVOSET LLC (US) 2018-02-27 US disclosed
US-20120049106-A1 MALEIMIDE-FUNCTIONAL MONOMERS IN AMORPHOUS FORM DESIGNER MOLECULES, INC. (US) 2012-03-01 US disclosed
US-20120049106-A1 MALEIMIDE-FUNCTIONAL MONOMERS IN AMORPHOUS FORM DESIGNER MOLECULES, INC. (US) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10358418-B2 Resin compositions ITGAM, TIAM1, PICALM MGLL 2171/4885FAAH 3685/4885HSP90AA1 1224/4885
US-20180170873-A1 RESIN COMPOSITIONS ITGAM, TIAM1, PICALM MGLL 2171/4885FAAH 3685/4885HSP90AA1 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.